• Home
  • Science
  • Pipeline
  • Team
  • Contact

Team

  • Leadership
  • Board of Directors

Ron Park, MD, MBA

Chief Executive Officer

Francine Gregoire, PhD

Chief Scientific Officer

Priya Parameswaran, MBA

Chief Business Officer

Grady Snyder, MBA

VP of Operations

Joy Branford, MS

VP of People & Culture

Lawrence Kong, PhD, JD

Executive Director of IP and Legal

Greg Cost, PhD

VP of Scientific Strategy

Matthew R. Patterson

Chairman

Peter Bisgaard

Board member

Matt Cohen, PhD

Board observer

Kathleen Collins, PhD

Board member

Jeni Lee, PhD

Board member

Graham Mills, PhD

Board observer

Ron Park, MD, MBA

Board member

Jayson Punwani, PhD, MBA

Board member

Laetitia Schwab, PhD

Board member

EXPLORE:

  • Home
  • Science
  • Pipeline
  • Team
  • Contact

MEET US:

©2026 Addition Therapeutics™. Privacy Policy. Terms of Use .